Please Wait.....
Report
LATAM Advanced Wound Care - Company Evaluation Report, 2025
Market Report I 2025-08-01 I 116 Pages I MarketsandMarkets
The Latin America (LATAM) advanced wound care Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Latin America (LATAM) advanced wound care. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and industry trends. MarketsandMarkets 360 Quadrants evaluated over 106 companies, of which the Top 11 Latin America (LATAM) advanced wound care Companies were categorized and recognized as quadrant leaders.
The Latin America (LATAM) advanced wound care market encompasses a portfolio of specialized medical products designed for the treatment of complex, chronic, and hard-to-heal wounds. This category moves beyond traditional dressings to include technologies that actively promote healing. Key products are advanced dressings like hydrocolloids, foams, and alginates that maintain a moist wound environment, as well as active therapies such as Negative Pressure Wound Therapy (NPWT), bio-engineered skin substitutes, and Latin America (LATAM) advanced wound careal growth factors. These solutions are vital for managing diabetic ulcers, venous leg ulcers, and pressure sores.
Market growth in the LATAM region is strongly driven by pressing public health trends, most notably the rising prevalence of diabetes and obesity, which has led to a corresponding increase in chronic wounds like diabetic foot ulcers. A growing geriatric population, more prone to such conditions, also contributes to demand. Furthermore, increasing awareness among clinicians of the proven benefits of advanced wound care, coupled with steadily improving healthcare infrastructure and expenditure in major economies like Brazil, Mexico, and Colombia, is expanding patient access to these modern treatment options.
However, the market faces significant regional challenges. The high cost of advanced wound care products remains a substantial barrier to widespread adoption across the economically diverse countries of Latin America, where public healthcare budgets can be constrained. A shortage of healthcare professionals trained in the proper application of these specialized therapies can limit their effectiveness. The complex logistics of distributing medical products across a vast and geographically varied continent also pose a challenge. A continued reliance on lower-cost traditional dressings in some healthcare systems can further slow market penetration.
The 360 Quadrant maps the Latin America (LATAM) advanced wound care companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Latin America (LATAM) advanced wound care quadrant. The top criteria for product footprint evaluation included Product [Foam Dressings, Silicon Dressings (Bordered Silicon Dressings, Non-bordered Silicon Dressings), Non-silicon Dressings, Xeroform Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Gelling Fiber Dressings, Collagen Dressings, Other Advanced Dressings], Wound Type [Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Other Chronic Wounds), Acute Wounds (Surgical & Traumatic Wounds, Burns)], End User (Hospitals & Clinics, Ambulatory Surgery Centers, Home Care Settings, Other End Users)
Key Players:
Major vendors in the Latin America (LATAM) advanced wound care market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Molnlycke AB (Sweden), Essity Aktiebolag (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Coloplast Group (Denmark), Integra LifeSciences Corporation (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), Lohmann & Rauscher GmbH & Co. KG (Germany), Medline Industries, LP (US), AVERY DENNISON CORPORATION (US), Hollister Incorporated (US), DeRoyal Industries, Inc. (US), Winner Medical Co., Ltd. (China), Baihe Medical (China), and Cremer S.A (Brazil). The key strategies major vendors implement in the Latin America (LATAM) advanced wound care market are partnerships, collaborations, product launches, and product enhancements.
Solventum
Following its 2024 spin-off from 3M, Solventum has emerged as a major independent healthcare leader. The company commands a significant market presence across key segments including Medical Surgical, Dental Solutions, and Health Information Systems. Leveraging deep expertise in material and data science, Solventum offers a vast portfolio of trusted products, from advanced wound care to clinical documentation software. Its strategic focus on solving critical patient needs while driving growth and margin expansion solidifies its position as a well-capitalized, global medtech innovator poised for continued market influence.
Smith+Nephew
Smith+Nephew is a leading global medical technology company with a strong portfolio in Orthopaedics, Sports Medicine, and Advanced Wound Management. The British multinational is renowned for its hip and knee implants, minimally invasive surgical tools, and advanced wound care products. A central element of its strategy is driving the adoption of its CORI robotic-assisted surgical system, a key differentiator in the orthopaedics market. Through a focus on innovation in its core segments and a strategic plan to improve operational performance, Smith+Nephew is working to accelerate growth and strengthen its competitive position worldwide.
Cardinal Health
Cardinal Health is an essential pillar of the US healthcare system, operating as a leading pharmaceutical distributor and a major manufacturer of medical supplies. The company's vast logistics network ensures the daily delivery of medicines to pharmacies and hospitals across the nation. Strategically, Cardinal Health is focused on enhancing the growth and profitability of its Medical segment, which produces its own brand of surgical and laboratory products. While optimizing its core distribution business, the company is also investing in high-growth areas like specialty pharmaceuticals, solidifying its critical role in the healthcare supply chain.
1 INTRODUCTION 12
1.1 MARKET DEFINITION 12
1.2 INCLUSIONS & EXCLUSIONS 12
1.3 STAKEHOLDERS 13
2 EXECUTIVE SUMMARY 14
3 MARKET OVERVIEW 17
3.1 INTRODUCTION 17
3.2 MARKET DYNAMICS 17
3.2.1 DRIVERS 18
3.2.1.1 Increasing incidence of chronic conditions impairing wound healing 18
3.2.1.1.1 Expansion of geriatric population and emergence of
age-associated syndromes 18
3.2.1.1.2 Rising incidence of diabetes 18
3.2.1.1.3 Increasing cases of obesity 19
3.2.1.2 Growing number of burn injuries 20
3.2.1.3 Rising trauma cases and road accidents 20
3.2.2 RESTRAINTS 20
3.2.2.1 High cost of advanced wound care products 20
3.2.2.2 Risks associated with advanced wound care products 21
3.2.3 OPPORTUNITIES 22
3.2.3.1 Expansion of healthcare infrastructure and uptake of
advanced technologies 22
3.2.3.2 Universal health coverage 22
3.2.4 CHALLENGES 22
3.2.4.1 Shortage of skilled healthcare professionals 22
3.2.4.2 Complications associated with delayed diagnosis and
limited awareness 23
3.3 VALUE CHAIN ANALYSIS 23
3.3.1 RESEARCH & DEVELOPMENT (R&D) 23
3.3.2 MANUFACTURING 24
3.3.3 DISTRIBUTION AND MARKETING & SALES 24
3.3.4 POST-SALES SERVICES 24
3.4 SUPPLY CHAIN ANALYSIS 24
3.4.1 PROMINENT COMPANIES 24
3.4.2 SMALL & MEDIUM-SIZED ENTERPRISES 25
3.4.3 END USERS 25
3.5 ECOSYSTEM ANALYSIS 25
?
3.6 PORTER'S FIVE FORCES ANALYSIS 26
3.6.1 THREAT OF NEW ENTRANTS 28
3.6.2 THREAT OF SUBSTITUTES 28
3.6.3 BARGAINING POWER OF SUPPLIERS 28
3.6.4 BARGAINING POWER OF BUYERS 28
3.6.5 INTENSITY OF COMPETITIVE RIVALRY 28
3.7 TECHNOLOGY ANALYSIS 29
3.7.1 KEY TECHNOLOGIES 29
3.7.1.1 Portable Negative Pressure Wound Therapy (NPWT) devices 29
3.7.2 ADJACENT TECHNOLOGIES 29
3.7.2.1 Telemedicine for wound care 29
3.7.3 COMPLEMENTARY TECHNOLOGIES 30
3.7.3.1 Antimicrobial wound dressings 30
3.8 PATENT ANALYSIS 30
3.9 KEY CONFERENCES & EVENTS, 2025 31
3.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 32
3.11 IMPACT OF AI/GENERATIVE AI ON LATAM ADVANCED WOUND CARE MARKET 32
3.11.1 INTRODUCTION 32
3.11.2 POTENTIAL OF AI IN ADVANCED WOUND CARE 33
3.11.3 AI USE CASES 33
3.11.4 FUTURE OF GENERATIVE AI ON ADVANCED WOUND CARE 34
4 COMPETITIVE LANDSCAPE 35
4.1 OVERVIEW 35
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 35
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET 35
4.3 REVENUE ANALYSIS, 2021?2023 36
4.4 MARKET SHARE ANALYSIS, 2024 37
4.5 COMPANY VALUATION AND FINANCIAL METRICS 40
4.5.1 COMPANY VALUATION 40
4.5.2 FINANCIAL METRICS 40
4.6 BRAND/PRODUCT COMPARISON 41
4.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 41
4.7.1 STARS 42
4.7.2 EMERGING LEADERS 42
4.7.3 PERVASIVE PLAYERS 42
4.7.4 PARTICIPANTS 42
4.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 44
4.7.5.1 Company footprint 44
4.7.5.2 Region footprint 45
4.7.5.3 Product footprint 46
4.7.5.4 Wound type footprint 47
4.7.5.5 End-user footprint 48
4.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 49
4.8.1 PROGRESSIVE COMPANIES 49
4.8.2 RESPONSIVE COMPANIES 49
4.8.3 DYNAMIC COMPANIES 49
4.8.4 STARTING BLOCKS 49
4.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 50
4.8.5.1 Detailed list of key startups/SMEs 50
4.8.5.2 Competitive benchmarking of key startups/SMEs 51
4.9 COMPETITIVE SCENARIO 52
4.9.1 PRODUCT LAUNCHES 52
4.9.2 DEALS 52
4.9.3 EXPANSIONS 53
4.9.4 OTHER DEVELOPMENTS 54
5 COMPANY PROFILES 55
5.1 KEY PLAYERS 55
5.1.1 SOLVENTUM 55
5.1.1.1 Business overview 55
5.1.1.2 Products offered 56
5.1.1.3 Recent developments 58
5.1.1.3.1 Other developments 58
5.1.1.4 MnM view 58
5.1.1.4.1 Right to win 58
5.1.1.4.2 Strategic choices 58
5.1.1.4.3 Weaknesses & competitive threats 58
5.1.2 MOLNLYCKE AB 59
5.1.2.1 Business overview 59
5.1.2.2 Products offered 60
5.1.2.3 Recent developments 61
5.1.2.3.1 Deals 61
5.1.2.4 MnM view 62
5.1.2.4.1 Right to win 62
5.1.2.4.2 Strategic choices 62
5.1.2.4.3 Weaknesses & competitive threats 62
5.1.3 COLOPLAST GROUP 63
5.1.3.1 Business overview 63
5.1.3.2 Products offered 64
5.1.3.3 Recent developments 65
5.1.3.3.1 Deals 65
?
5.1.3.4 MnM view 65
5.1.3.4.1 Right to win 65
5.1.3.4.2 Strategic choices 65
5.1.3.4.3 Weaknesses & competitive threats 65
5.1.4 SMITH+NEPHEW 66
5.1.4.1 Business overview 66
5.1.4.2 Products offered 67
5.1.4.3 Recent developments 68
5.1.4.3.1 Deals 68
5.1.4.3.2 Expansions 69
5.1.4.3.3 Other developments 69
5.1.4.4 MnM view 70
5.1.4.4.1 Right to win 70
5.1.4.4.2 Strategic choices 70
5.1.4.4.3 Weaknesses & competitive threats 70
5.1.5 CONVATEC GROUP PLC 71
5.1.5.1 Business overview 71
5.1.5.2 Products offered 72
5.1.5.3 Recent developments 73
5.1.5.3.1 Product launches/approvals/enhancements 73
5.1.5.3.2 Deals 73
5.1.5.4 MnM view 74
5.1.5.4.1 Right to win 74
5.1.5.4.2 Strategic choices 74
5.1.5.4.3 Weaknesses & competitive threats 74
5.1.6 CARDINAL HEALTH 75
5.1.6.1 Business overview 75
5.1.6.2 Products offered 76
5.1.6.3 Recent developments 77
5.1.6.3.1 Expansions 77
5.1.7 B. BRAUN SE 78
5.1.7.1 Business overview 78
5.1.7.2 Products offered 79
5.1.7.3 Recent developments 80
5.1.7.3.1 Deals 80
5.1.7.3.2 Expansions 80
5.1.8 ESSITY AKTIEBOLAG 81
5.1.8.1 Business overview 81
5.1.8.2 Products offered 82
5.1.8.3 Recent developments 83
5.1.8.3.1 Deals 83
5.1.8.3.2 Expansions 83
5.1.9 PAUL HARTMANN AG 84
5.1.9.1 Business overview 84
5.1.9.2 Products offered 85
5.1.9.3 Recent developments 86
5.1.9.3.1 Deals 86
5.1.10 INTEGRA LIFESCIENCES CORPORATION 87
5.1.10.1 Business overview 87
5.1.10.2 Products offered 88
5.1.10.3 Recent developments 89
5.1.10.3.1 Deals 89
5.1.10.3.2 Expansions 89
5.1.11 MATIV HOLDINGS, INC. 90
5.1.11.1 Business overview 90
5.1.11.2 Products offered 91
5.1.11.3 Recent developments 92
5.1.11.3.1 Deals 92
5.1.12 OWENS & MINOR 93
5.1.12.1 Business overview 93
5.1.12.2 Products offered 94
5.1.12.3 Recent developments 95
5.1.12.3.1 Deals 95
5.1.13 AVERY DENNISON CORPORATION 96
5.1.13.1 Business overview 96
5.1.13.2 Products offered 97
5.1.13.3 Recent developments 98
5.1.13.3.1 Deals 98
5.1.13.3.2 Expansions 98
5.2 OTHER PLAYERS 99
5.2.1 LOHMANN & RAUSCHER GMBH & CO. KG 99
5.2.2 MEDLINE INDUSTRIES, LP 100
5.2.3 FERRIS MFG. CORP. 101
5.2.4 TRIAGE MEDTECH 101
5.2.5 MISSNER & MISSNER LTDA 102
5.2.6 DEROYAL INDUSTRIES, INC. 103
5.2.7 HOLLISTER INCORPORATED 104
5.2.8 WINNER MEDICAL CO., LTD. 105
5.2.9 URGO MEDICAL 106
5.2.10 BAIHE MEDICAL 106
5.2.11 CREMER S.A. 107
5.2.12 ADVANCIS (UK) 108
?
6 APPENDIX 109
6.1 RESEARCH METHODOLOGY 109
6.1.1 RESEARCH DATA 109
6.1.1.1 Secondary data 109
6.1.1.2 Primary data 110
6.1.2 RESEARCH ASSUMPTIONS 112
6.1.3 RISK ASSESSMENT 112
6.1.4 RESEARCH LIMITATIONS 113
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 113
6.3 AUTHOR DETAILS 116
TABLE 1 LATAM ADVANCED WOUND CARE MARKET: INCLUSIONS & EXCLUSIONS 12
TABLE 2 PEOPLE WITH DIABETES (20-79 YEARS), BY COUNTRY,
2021 VS. 2045 (IN THOUSANDS) 19
TABLE 3 PREVALENCE OF OVERWEIGHT ADULTS, BMI ? 25 KG/M (AGE-STANDARDIZED ESTIMATE) (%); 18+ YEARS IN LATIN AMERICA, MALE & FEMALE 19
TABLE 4 AVERAGE TREATMENT COST FOR DIABETIC FOOT ULCERS 21
TABLE 5 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 21
TABLE 6 LATAM ADVANCED WOUND CARE MARKET: ROLE IN ECOSYSTEM 26
TABLE 7 LATAM ADVANCED WOUND CARE MARKET: PORTER'S FIVE FORCES ANALYSIS 27
TABLE 8 LATAM ADVANCED WOUND CARE MARKET: KEY CONFERENCES & EVENTS, 2025 31
TABLE 9 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
LATAM ADVANCED WOUND CARE MARKET, 2022-2025 35
TABLE 10 LATAM ADVANCED WOUND CARE MARKET: DEGREE OF COMPETITION 38
TABLE 11 LATAM ADVANCED WOUND CARE MARKET: REGION FOOTPRINT 45
TABLE 12 LATAM ADVANCED WOUND CARE MARKET: PRODUCT FOOTPRINT 46
TABLE 13 LATAM ADVANCED WOUND CARE MARKET: WOUND TYPE FOOTPRINT 47
TABLE 14 LATAM ADVANCED WOUND CARE MARKET: END-USER FOOTPRINT 48
TABLE 15 LATAM ADVANCED WOUND CARE MARKET:
DETAILED LIST OF KEY STARTUPS/SMES 50
TABLE 16 LATAM ADVANCED WOUND CARE MARKET:
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 51
TABLE 17 LATAM ADVANCED WOUND CARE MARKET:
PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2025 52
TABLE 18 LATAM ADVANCED WOUND CARE MARKET:
DEALS, JANUARY 2022-FEBRUARY 2025 52
TABLE 19 LATAM ADVANCED WOUND CARE MARKET:
EXPANSIONS, JANUARY 2022-FEBRUARY 2025 53
TABLE 20 LATAM ADVANCED WOUND CARE MARKET:
OTHER DEVELOPMENTS, JANUARY 2022?FEBRUARY 2025 54
TABLE 21 SOLVENTUM: COMPANY OVERVIEW 55
TABLE 22 SOLVENTUM: PRODUCTS OFFERED 56
TABLE 23 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2021-FEBRUARY 2025 58
TABLE 24 MOLNLYCKE AB: COMPANY OVERVIEW 59
TABLE 25 MOLNLYCKE AB: PRODUCTS OFFERED 60
TABLE 26 MOLNLYCKE AB: DEALS, JANUARY 2021-FEBRUARY 2025 61
TABLE 27 COLOPLAST GROUP: COMPANY OVERVIEW 63
TABLE 28 COLOPLAST GROUP: PRODUCTS OFFERED 64
TABLE 29 COLOPLAST GROUP: DEALS, JANUARY 2021-FEBRUARY 2025 65
TABLE 30 SMITH+NEPHEW: COMPANY OVERVIEW 66
TABLE 31 SMITH+NEPHEW: PRODUCTS OFFERED 67
TABLE 32 SMITH+NEPHEW: DEALS, JANUARY 2021-FEBRUARY 2025 68
TABLE 33 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021-FEBRUARY 2025 69
TABLE 34 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2021-FEBRUARY 2025 69
TABLE 35 CONVATEC GROUP PLC: COMPANY OVERVIEW 71
TABLE 36 CONVATEC GROUP PLC: PRODUCTS OFFERED 72
TABLE 37 CONVATEC GROUP PLC: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2021-FEBRUARY 2025 73
TABLE 38 CONVATEC GROUP PLC: DEALS, JANUARY 2021-FEBRUARY 2025 73
TABLE 39 CARDINAL HEALTH: COMPANY OVERVIEW 75
TABLE 40 CARDINAL HEALTH: PRODUCTS OFFERED 76
TABLE 41 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021-FEBRUARY 2025 77
TABLE 42 B. BRAUN SE: COMPANY OVERVIEW 78
TABLE 43 B. BRAUN SE: PRODUCTS OFFERED 79
TABLE 44 B. BRAUN SE: DEALS, JANUARY 2021-FEBRUARY 2025 80
TABLE 45 B. BRAUN SE: EXPANSIONS, JANUARY 2021-FEBRUARY 2025 80
TABLE 46 ESSITY AKTIEBOLAG: COMPANY OVERVIEW 81
TABLE 47 ESSITY AKTIEBOLAG: PRODUCTS OFFERED 82
TABLE 48 ESSITY AKTIEBOLAG: DEALS, JANUARY 2021-FEBRUARY 2025 83
TABLE 49 ESSITY AKTIEBOLAG: EXPANSIONS, JANUARY 2021-FEBRUARY 2025 83
TABLE 50 PAUL HARTMANN AG: COMPANY OVERVIEW 84
TABLE 51 PAUL HARTMANN AG: PRODUCTS OFFERED 85
TABLE 52 PAUL HARTMANN AG: DEALS, JANUARY 2021-FEBRUARY 2025 86
TABLE 53 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 87
TABLE 54 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 88
TABLE 55 INTEGRA LIFESCIENCES: DEALS JANUARY 2021-FEBRUARY 2025 89
TABLE 56 INTEGRA LIFESCIENCES CORPORATION:
EXPANSIONS, JANUARY 2021-FEBRUARY 2025 89
TABLE 57 MATIV HOLDINGS, INC.: COMPANY OVERVIEW 90
TABLE 58 MATIV HOLDINGS, INC.: PRODUCTS OFFERED 91
TABLE 59 MATIV HOLDINGS, INC.: DEALS, JANUARY 2021-FEBRUARY 2025 92
TABLE 60 OWENS & MINOR: COMPANY OVERVIEW 93
TABLE 61 OWENS & MINOR: PRODUCTS OFFERED 94
TABLE 62 OWENS & MINOR: DEALS, JANUARY 2021-FEBRUARY 2025 95
TABLE 63 AVERY DENNISON CORPORATION: COMPANY OVERVIEW 96
TABLE 64 AVERY DENNISON CORPORATION: PRODUCTS OFFERED 97
TABLE 65 AVERY DENNISON CORPORATION: DEALS, JANUARY 2021-FEBRUARY 2025 98
TABLE 66 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2021-FEBRUARY 2025 98
TABLE 67 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 99
TABLE 68 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 100
TABLE 69 FERRIS MFG. CORP.: COMPANY OVERVIEW 101
TABLE 70 TRIAGE MEDTECH: COMPANY OVERVIEW 101
TABLE 71 MISSNER & MISSNER LTDA: COMPANY OVERVIEW 102
TABLE 72 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 103
TABLE 73 HOLLISTER INCORPORATED: COMPANY OVERVIEW 104
TABLE 74 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW 105
TABLE 75 URGO MEDICA: COMPANY OVERVIEW 106
TABLE 76 BAIHE MEDICAL: COMPANY OVERVIEW 106
TABLE 77 CREMER S.A.: COMPANY OVERVIEW 107
TABLE 78 ADVANCIS (UK): COMPANY OVERVIEW 108
TABLE 79 KEY DATA FROM PRIMARY SOURCES 111
TABLE 80 LATAM ADVANCED WOUND CARE WOUND CARE MARKET: RISK ASSESSMENT 112
FIGURE 1 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 14
FIGURE 2 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE,
2025 VS. 2030 (USD MILLION) 15
FIGURE 3 LATAM ADVANCED WOUND CARE MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 15
FIGURE 4 GEOGRAPHIC SNAPSHOT OF LATAM ADVANCED WOUND CARE MARKET 16
FIGURE 5 LATAM ADVANCED WOUND CARE MARKET:
DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 17
FIGURE 6 LATAM ADVANCED WOUND CARE MARKET: VALUE CHAIN ANALYSIS 24
FIGURE 7 LATAM ADVANCED WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS 25
FIGURE 8 LATAM ADVANCED WOUND CARE MARKET: ECOSYSTEM ANALYSIS 26
FIGURE 9 LATAM ADVANCED WOUND CARE MARKET: PORTER'S FIVE FORCES ANALYSIS 27
FIGURE 10 LATAM ADVANCED WOUND CARE MARKET:
PATENT ANALYSIS, JANUARY 2015-MARCH 2024 31
FIGURE 11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 32
FIGURE 12 REVENUE ANALYSIS OF KEY PLAYERS, 2021?2023 (USD MILLION) 37
FIGURE 13 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 38
FIGURE 14 RANKING OF KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET, 2024 39
FIGURE 15 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND
5-YEAR STOCK BETA OF KEY VENDORS, 2025 40
FIGURE 16 FINANCIAL METRICS, 2025 40
FIGURE 17 LATAM ADVANCED WOUND CARE MARKET: BRAND/PRODUCT COMPARISON 41
FIGURE 18 LATAM ADVANCED WOUND CARE MARKET:
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 43
FIGURE 19 LATAM ADVANCED WOUND CARE MARKET: COMPANY FOOTPRINT 44
FIGURE 20 LATAM ADVANCED WOUND CARE MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 50
FIGURE 21 SOLVENTUM: COMPANY SNAPSHOT (2024) 56
FIGURE 22 MOLNLYCKE AB: COMPANY SNAPSHOT (2023) 60
FIGURE 23 COLOPLAST GROUP: COMPANY SNAPSHOT (2024) 64
FIGURE 24 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 67
FIGURE 25 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2023) 72
FIGURE 26 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 76
FIGURE 27 B. BRAUN SE: COMPANY SNAPSHOT (2023) 79
FIGURE 28 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024) 82
FIGURE 29 PAUL HARTMANN AG: COMPANY SNAPSHOT (2023) 85
FIGURE 30 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023) 88
FIGURE 31 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024) 91
FIGURE 32 OWENS & MINOR: COMPANY SNAPSHOT (2024) 94
FIGURE 33 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024) 97
FIGURE 34 LATAM ADVANCED WOUND CARE MARKET: RESEARCH DESIGN 109
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security